Expression and regulation of a novel identified TNFAIP8 family is associated with diabetic nephropathy

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1802, Issue 11, 2010, Pages 1078-1086

  Zhang, Shuya ^a   Zhang, Yan ^a   Wei, Xinbing ^a   Zhen, Junhui ^a   Wang, Ziying ^a   Li, Minyong ^b   Miao, Wei ^c   Ding, Hua ^a   Du, Pengchao ^a   Zhang, Wenchao ^a   He, Min ^a   Yi, Fan ^a  

^a SHANDONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANDONG UNIVERSITY   (China)

^c JINAN CENTRAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

Author keywords

Cell proliferation; Diabetic nephropathy; Immune homeostasis; NADPH oxidase; TNFAIP8 family

Indexed keywords

PROTEIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TUMOR NECROSIS FACTOR ALPHA INDUCIBLE PROTEIN 8; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DIABETIC NEPHROPATHY; HUMAN; HUMAN TISSUE; MALE; MESANGIUM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; RAT; SIGNAL TRANSDUCTION; STREPTOZOCIN DIABETES;

ANIMALS; APOPTOSIS REGULATORY PROTEINS; BLOTTING, WESTERN; CELLS, CULTURED; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; GLUCOSE; HUMANS; IMMUNOHISTOCHEMISTRY; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KIDNEY; KIDNEY GLOMERULUS; MALE; MESANGIAL CELLS; NADPH OXIDASE; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE;

RATTUS;

EID: 77956650935     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbadis.2010.08.003     Document Type: Article

References (37)

1. Pozzi A., Zent R., Chetyrkin S., Borza C., Bulus N., Chuang P., Chen D., Hudson B., Voziyan P. Modification of collagen IV by glucose or methylglyoxal alters distinct mesangial cell functions. J. Am. Soc. Nephrol. 2009, 20:2119-2125.
2. Qian Y., Feldman E., Pennathur S., Kretzler M., Brosius F.C. From fibrosis to sclerosis: mechanisms of glomerulosclerosis in diabetic nephropathy. Diabetes 2008, 57:1439-1445.
3. Navarro J.F., Milena F.J., Mora C., Leon C., Garcia J. Renal pro-inflammatory cytokine gene expression in diabetic nephropathy: effect of angiotensin-converting enzyme inhibition and pentoxifylline administration. Am. J. Nephrol. 2006, 26:562-570.
4. Yozai K., Shikata K., Sasaki M., Tone A., Ohga S., Usui H., Okada S., Wada J., Nagase R., Ogawa D., Shikata Y., Makino H. Methotrexate prevents renal injury in experimental diabetic rats via anti-inflammatory actions. J. Am. Soc. Nephrol. 2005, 16:3326-3338.
5. Lai K.N., Leung J.C., Chan L.Y., Saleem M.A., Mathieson P.W., Tam K.Y., Xiao J., Lai F.M., Tang S.C. Podocyte injury induced by mesangial-derived cytokines in IgA nephropathy. Nephrol. Dial. Transplant. 2009, 24:62-72.
6. Wong H., Mylrea K., Feber J., Drukker A., Filler G. Prevalence of complications in children with chronic kidney disease according to KDOQI. Kidney Int. 2006, 70:585-590.
7. Freundt E.C., Bidere N., Lenardo M.J. A different TIPE of immune homeostasis. Cell 2008, 133:401-402.
8. Sun H., Gong S., Carmody R.J., Hilliard A., Li L., Sun J., Kong L., Xu L., Hilliard B., Hu S., Shen H., Yang X., Chen Y.H. TIPE2, a negative regulator of innate and adaptive immunity that maintains immune homeostasis. Cell 2008, 133:415-426.
9. Patel S., Wang F.H., Whiteside T.L., Kasid U. Identification of seven differentially displayed transcripts in human primary and matched metastatic head and neck squamous cell carcinoma cell lines: implications in metastasis and/or radiation response. Oral Oncol. 1997, 33:197-203.
10. Romanuik T.L., Ueda T., Le N., Haile S., Yong T.M., Thomson T., Vessella R.L., Sadar M.D. Novel biomarkers for prostate cancer including noncoding transcripts. Am. J. Pathol. 2009, 175:2264-2276.
11. Zhang C., Chakravarty D., Sakabe I., Mewani R.R., Boudreau H.E., Kumar D., Ahmad I., Kasid U.N. Role of SCC-S2 in experimental metastasis and modulation of VEGFR-2, MMP-1, and MMP-9 expression. Mol. Ther. 2006, 13:947-955.
12. Kumar D., Gokhale P., Broustas C., Chakravarty D., Ahmad I., Kasid U. Expression of SCC-S2, an antiapoptotic molecule, correlates with enhanced proliferation and tumorigenicity of MDA-MB 435 cells. Oncogene 2004, 23:612-616.
13. Zhang X., Wang J., Fan C., Li H., Sun H., Gong S., Chen Y.H., Shi Y. Crystal structure of TIPE2 provides insights into immune homeostasis. Nat. Struct. Mol. Biol. 2009, 16:89-90.
14. Yi F., Xia M., Li N., Zhang C., Tang L., Li P.L. Contribution of guanine nucleotide exchange factor Vav2 to hyperhomocysteinemic glomerulosclerosis in rats. Hypertension 2009, 53:90-96.
15. Yi F., Zhang A.Y., Li N., Muh R.W., Fillet M., Renert A.F., Li P.L. Inhibition of ceramide-redox signaling pathway blocks glomerular injury in hyperhomocysteinemic rats. Kidney Int. 2006, 70:88-96.
16. Wang Z., Wei X., Zhang Y., Ma X., Li B., Zhang S., Du P., Zhang X., Yi F. NADPH oxidase-derived ROS contributes to upregulation of TRPC6 expression in puromycin aminonucleoside-induced podocyte injury. Cell. Physiol. Biochem. 2009, 24:619-626.
17. Yi F., Zhang A.Y., Janscha J.L., Li P.L., Zou A.P. Homocysteine activates NADH/NADPH oxidase through ceramide-stimulated Rac GTPase activity in rat mesangial cells. Kidney Int. 2004, 66:1977-1987.
18. Lagranha C.J., Alba-Loureiro T.C., Martins E.F., Pithon-Curi T.C., Curi R. Neutrophil fatty acid composition: effect of a single session of exercise and glutamine supplementation. Amino Acids 2008, 35:243-245.
19. Tibbetts M.D., Zheng L., Lenardo M.J. The death effector domain protein family: regulators of cellular homeostasis. Nat. Immunol. 2003, 4:404-409.
20. Wang J., Chun H.J., Wong W., Spencer D.M., Lenardo M.J. Caspase-10 is an initiator caspase in death receptor signaling. Proc. Natl Acad. Sci. USA 2001, 98:13884-13888.
21. Zhang J., Cado D., Chen A., Kabra N.H., Winoto A. Fas-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD/Mort1. Nature 1998, 392:296-300.
22. Walsh C.M., Wen B.G., Chinnaiyan A.M., O'Rourke K., Dixit V.M., Hedrick S.M. A role for FADD in T cell activation and development. Immunity 1998, 8:439-449.
23. Chang D.W., Xing Z., Pan Y., Algeciras-Schimnich A., Barnhart B.C., Yaish-Ohad S., Peter M.E., Yang X. c-FLIP(L) is a dual function regulator for caspase-8 activation and CD95-mediated apoptosis. EMBO J. 2002, 21:3704-3714.
24. Thome M., Schneider P., Hofmann K., Fickenscher H., Meinl E., Neipel F., Mattmann C., Burns K., Bodmer J.L., Schroter M., Scaffidi C., Krammer P.H., Peter M.E., Tschopp J. Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors. Nature 1997, 386:517-521.
25. Condorelli G., Vigliotta G., Cafieri A., Trencia A., Andalo P., Oriente F., Miele C., Caruso M., Formisano P., Beguinot F. PED/PEA-15: an anti-apoptotic molecule that regulates FAS/TNFR1-induced apoptosis. Oncogene 1999, 18:4409-4415.
26. Ramos J.W., Hughes P.E., Renshaw M.W., Schwartz M.A., Formstecher E., Chneiweiss H., Ginsberg M.H. Death effector domain protein PEA-15 potentiates Ras activation of extracellular signal receptor-activated kinase by an adhesion-independent mechanism. Mol. Biol. Cell 2000, 11:2863-2872.
27. Yano N., Suzuki D., Endoh M., Cao T.N., Dahdah J.R., Tseng A., Stabila J.P., McGonnigal B.G., Padbury J.F., Tseng Y.T. High ambient glucose induces angiotensin-independent AT-1 receptor activation, leading to increases in proliferation and extracellular matrix accumulation in MES-13 mesangial cells. Biochem. J. 2009, 423:129-143.
28. Cove-Smith A., Hendry B.M. The regulation of mesangial cell proliferation. Nephron Exp. Nephrol. 2008, 108:e74-e79.
29. Marasa M., Kopp J.B. Monoclonal antibodies for podocytopathies: rationale and clinical responses. Nat. Rev. Nephrol. 2009, 5:337-348.
30. Niranjan T., Murea M., Susztak K. The pathogenic role of Notch activation in podocytes. Nephron Exp. Nephrol. 2009, 111:e73-e79.
31. Paravicini T.M., Touyz R.M. NADPH oxidases, reactive oxygen species, and hypertension: clinical implications and therapeutic possibilities. Diab. Care 2008, 31(Suppl 2):S170-S180.
32. Gill P.S., Wilcox C.S. NADPH oxidases in the kidney. Antioxid. Redox Signal. 2006, 8:1597-1607.
33. Gorin Y., Block K., Hernandez J., Bhandari B., Wagner B., Barnes J.L., Abboud H.E. Nox4 NAD(P)H oxidase mediates hypertrophy and fibronectin expression in the diabetic kidney. J. Biol. Chem. 2005, 280:39616-39626.
34. Etoh T., Inoguchi T., Kakimoto M., Sonoda N., Kobayashi K., Kuroda J., Sumimoto H., Nawata H. Increased expression of NAD(P)H oxidase subunits, NOX4 and p22phox, in the kidney of streptozotocin-induced diabetic rats and its reversibility by interventive insulin treatment. Diabetologia 2003, 46:1428-1437.
35. Lee I.T., Luo S.F., Lee C.W., Wang S.W., Lin C.C., Chang C.C., Chen Y.L., Chau L.Y., Yang C.M. Overexpression of HO-1 protects against TNF-alpha-mediated airway inflammation by down-regulation of TNFR1-dependent oxidative stress. Am. J. Pathol. 2009, 175:519-532.
36. Min D., Lyons J.G., Bonner J., Twigg S.M., Yue D.K., McLennan S.V. Mesangial cell-derived factors alter monocyte activation and function through inflammatory pathways: possible pathogenic role in diabetic nephropathy. Am. J. Physiol. Renal. Physiol. 2009, 297:F1229-F1237.
37. Galkina E., Ley K. Leukocyte recruitment and vascular injury in diabetic nephropathy. J. Am. Soc. Nephrol. 2006, 17:368-377.